Study explorer (study characteristics and results) method abbreviations

display ongoing studies
Study studied treatmentcontrol treatmentpatientsrisk of biassample sizes Results

COVID-19 mild to moderate meta-analysis

Rastogi, 2020
RCTVitamin DplaceboCOVID-19 mild to moderateNA
16/24 suggested
  • suggested 5.3-fold increase in PCR-negative conversion (PE)

PE: primary endpoint; (a): to be demonstrated a result must be statistically significant on a primary endpoint (with multiplicity adjustment if necessary);